Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10155)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2016 (publication date) through Jan 15, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Rangan GK. C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria. World J Nephrol 2016; 5(3): 288-299 [PMID: 27152265 DOI: 10.5527/wjn.v5.i3.288] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Rangan GK. C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria. World J Nephrol 2016; 5(3): 288-299 [PMID: 27152265 DOI: 10.5527/wjn.v5.i3.288] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v5/i3/288.htm |
| Number | Citing Articles |
| 1 |
Agnes B. Fogo, Raymond C. Harris. Crosstalk between glomeruli and tubules. Nature Reviews Nephrology 2025; 21(3): 189 doi: 10.1038/s41581-024-00907-0
|
| 2 |
Firas F Alkaff, Rosa G M Lammerts, Mohamed R Daha, Stefan P Berger, Jacob van den Born. Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases. Clinical Kidney Journal 2024; 17(8) doi: 10.1093/ckj/sfae215
|
| 3 |
Firas F Alkaff, Rosa G M Lammerts, Gesa Tiller, Marius C van den Heuvel, Ingeborg M Bajema, Mohamed R Daha, Jacob van den Born, Stefan P Berger. Alternative pathway–mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept study. Clinical Kidney Journal 2025; 18(11) doi: 10.1093/ckj/sfaf320
|